Table 4 Predictive performance of key metabolic indicators for MAFLD, abnormal FBG, and their coexistence.

From: The association of multiple metabolic disorders with the severity of fasting blood glucose and hepatic steatosis in a Chinese population with MAFLD: a cross-sectional study of over 3000 participants

 

Optimal Cut-off

For MAFLD & Abnormal FBG (Primary Outcome)

For MAFLD Alone

For Abnormal FBG Alone

AUC (95% CI)

AUC (95% CI)

AUC (95% CI)

BMI(kg/m2)

24.835

0.906 (0.888–0.923)

0.873 (0.858–0.888)

0.638 (0.613–0.663)

SBP (mmHg)

132.5

0.777 (0.750–0.805)

–

0.653 (0.628–0.678)

TG (mmol/L)

1.655

0.795 (0.768–0.821)

0.740 (0.719–0.762)

0.629 (0.603–0.655)

ALT(IU/L)

27.5

0.749 (0.720–0.778)

0.720 (0.697–0.743)

0.588 (0.561–0.614)

  1. AUC, area under the curve; CI, confidence interval.
  2. A dash (-) indicates that SBP was not a significant predictor for MAFLD alone in the final model (as per the binary logistic regression analysis).
  3. Supplementary Table S1. Post Hoc Pairwise Comparisons of FBG Across Hepatic Steatosis Grades.
Back to article page